PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.

PHO：儿科血液学和肿瘤学涵盖了儿童血液疾病和恶性疾病领域研究和患者管理的所有方面。我们的目标是让 PHO：儿科血液学和肿瘤学成为国际临床医生和科学家社区的顶级期刊，他们共同致力于为患有癌症和血液疾病的儿童和年轻人制定最佳治疗策略。该期刊支持涉及不同临床环境中的研究的文章、为发病机制和/或临床护理增加新见解的特殊案例研究/系列，以及强调联盟和会议中出现的发现和挑战的评论。临床研究以及有关癌症发病机制、遗传学、分子诊断、药理学、干细胞、分子靶向、细胞和免疫疗法以及移植的基础和转化研究报告都很有趣。我们也欢迎关注支持性护理、后期影响以及这些领域相关的伦理、法律、心理、社会、文化或历史方面的论文。欢迎对该领域重要发展的评论。考虑发表来自国际儿科血液学和肿瘤学界科学家和临床医生的文章。该期刊不依赖或与任何组织或协会有联系。所有投稿在发表前都经过严格的同行评审。我们的编辑委员会包括代表广泛学术和地域多样性的儿科血液学和肿瘤学专家。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-小儿科领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为1.2，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。